Cardiopulmonary Exercise Testing and the Evaluation of the Upper Airway Architecture
This presentation will identify the role of exercise testing in the evaluation of upper airway symptoms and the diagnostic tools available to evaluate the patient condition. This will include a discussion about flow-volume loop analysis and direct video-laryngoscopy performed during exercise.
This course is approved for 1.0 CRCE.
Speaker Information
Katrina Hynes MHA, RRT, RPFT
Cardiopulmonary Exercise Testing: Protocols and the Normal Physiologic Responses
Cardiopulmonary Exercise Testing (CPET) is a valuable tool for evaluating exercise capacity and predicting outcome in patients with various conditions. This presentation will discuss various devices and protocols used for CPET as well as the normal ventilatory responses to exercise.
This course is approved for 1.0 CRCE.
Speaker Information
Carl Mottram RRT, RPFT, FAARC
Diffusing Capacity: 2017 ATS/ERS Standards Implementation in the PF Lab
The measurement of diffusing capacity (DLCO) of the lung is accomplished through single-breath carbon monoxide uptake. In 2017, the American Thoracic Society (ATS) and European Respiratory Society (ERS) jointly updated their technical standards to improve the quality of this measurement. This presentation will review the changes to the previous standards as well as identify how these standards affect the pulmonary function laboratory.
This course is approved for 1.0 CRCE.
Speaker Information
Susan Blonshine BS, RRT, RPFT, AE-C, FAARC
FeNO – an airway biomarker: The what and why of Fractional Exhaled Nitric Oxide
The noninvasive measurement of exhaled nitric oxide (FeNO) may be useful in the diagnosis and treatment of respiratory diseases. This presentation will discuss the mechanism of FeNO production, how to interpret the test results, and how this measurement can be used in both pulmonary medicine and primary care.
This course is approved for 1.0 CRCE
Speaker Information
Kaiser Lim, MD
Indirect bronchoprovocation, better than a methacholine challenge?
In this session focused on bronchoprovocation tests, the presenter will focus on indirect bronchoprovocation. Indirect bronchoprovocation testing is focused on producing reactions in the airway smooth muscle cells by stimulating airway inflammatory cells and demonstrates high specificity and relatively low sensitivity. This presentation will differentiate indirect bronchoprovocation from direct and explore the effectiveness of various types of indirect testing.
This course is approved for 1.0 CRCE.
Speaker Information
Karina Keogh, MD
Pulmonary Function Technology: Advanced Concepts
The Pulmonary Function Technology: Advanced Concepts course was designed to improve the respiratory therapist's knowledge lung volumes testing, diffusing capacity testing, and quality assurance in the pulmonary function laboratory. This course offers a unique opportunity to learn from noted experts in the field.
This course is approved for 2.50 CRCE
Speaker Information
Gregg Ruppel MEd, RRT, RPFT, FAARC
Renato Galindo BSRC, RRT, CPFT, AE-C, TTS
Jeffrey Haynes RRT, RPFT
Pulmonary Function Technology: Pediatrics
The Pulmonary Function Technology: Pediatrics course was designed to improve the respiratory therapist's knowledge in various aspects of pulmonary function testing specific to infant and pediatric patients.
This course is approved for 4.50 CRCE.
Speaker Information
Deborah White RRT, RPFT, AE-C
Pulmonary Function Technology: Spirometry
This spirometry course will discuss obstructive and restrictive disease processes, basic measurements, reference values, repeatability and acceptability, and how to perform a quality procedure. Also discussed is calibration of the spirometer and patterns of abnormal results.
This course is approved for 2.0 CRCE.
Speaker Information
Curt Merriman BA, RRT, CPFT
Tickling or Irritating the Airways - Methacholine Challenge Testing
Respiratory therapists are vital to the accurate diagnosis of various pulmonary diseases and are the cornerstone of good pulmonary diagnostic tests. One of these tests, used to diagnose the reactivity of the airway, is the methacholine challenge test. While this test has been conducted for many years, recent guidelines and availability of medication have complicated the clinician's ability to recommend and conduct the challenge test. This presentation will explore the indications, methods, and technical aspects of the methacholine challenge test.
This course is approved for 1.0 CRCE.
Speaker Information
Kaiser Lim, MD
Carl D Mottram, RRT, RPFT, FAARC